InvestorsHub Logo
icon url

DR Ryan

11/14/13 9:22 PM

#77580 RE: Pharma Sleuth #77575

Yes, drives us to a profit while Epic takes care of all the work. Elite can focus on our ART and trials, which they're clearly doing.

"In addition to launching a new product and substantially increasing our revenues, we have set in motion several initiatives that will have significant impact on Elite's future," commented Nasrat Hakim, President and CEO of Elite. "During this quarter, we acquired 12 new approved products, greatly accelerated the development of our abuse resistant technology and are on schedule for clinical trials to begin this year."